Brokers Issue Forecasts for MNPR FY2026 EarningsMonopar Therapeutics Inc. (NASDAQ:MNPR - Free Report) - Equities research analysts at Brookline Capital Markets raised their FY2026 EPS estimates for shares of Monopar Therapeutics in a report released on Friday, November 13th. Brookline Capital Markets analyst K. Dolliver now expects that the compa...